Steven Gunawan

635 total citations
20 papers, 371 citations indexed

About

Steven Gunawan is a scholar working on Organic Chemistry, Molecular Biology and Hematology. According to data from OpenAlex, Steven Gunawan has authored 20 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 9 papers in Molecular Biology and 4 papers in Hematology. Recurrent topics in Steven Gunawan's work include Multicomponent Synthesis of Heterocycles (6 papers), Chemical Synthesis and Analysis (3 papers) and Protein Degradation and Inhibitors (3 papers). Steven Gunawan is often cited by papers focused on Multicomponent Synthesis of Heterocycles (6 papers), Chemical Synthesis and Analysis (3 papers) and Protein Degradation and Inhibitors (3 papers). Steven Gunawan collaborates with scholars based in United States and Indonesia. Steven Gunawan's co-authors include Christopher Hulme, Nicholas J. Lawrence, Harshani R. Lawrence, E. Schönbrunn, Gary S. Nichol, Muhammad Ayaz, Gary W. Reuther, Ryan R. Davis, Yuan Ren and Jie Wu and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Science Translational Medicine.

In The Last Decade

Steven Gunawan

19 papers receiving 363 citations

Peers

Steven Gunawan

HEMAT

IMMUN

ONCOL

Stephen C. Yabut United States

Stephanos Ioannidis United States

Andiliy Lai United States

Cyrille Kuhn United States

David J. Calderwood United States

Bo‐Tao Xin Netherlands

Suhong Pang United States

Audrey M. Davies United States

Marcel Koenig United States

Attilla Ting United Kingdom

Stephen C. Yabut United States

Steven Gunawan

210 ×1.2

205 ×1.3

50 ×0.6

HEMAT

46 ×0.8

IMMUN

37 ×0.6

ONCOL

Citations per year, relative to Steven Gunawan Steven Gunawan (= 1×) peers Stephen C. Yabut

Countries citing papers authored by Steven Gunawan

Since Specialization

Citations

This map shows the geographic impact of Steven Gunawan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Gunawan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Gunawan more than expected).

Fields of papers citing papers by Steven Gunawan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Gunawan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Gunawan. The network helps show where Steven Gunawan may publish in the future.

Co-authorship network of co-authors of Steven Gunawan

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Gunawan. A scholar is included among the top collaborators of Steven Gunawan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Gunawan. Steven Gunawan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gunawan, Steven, et al.. (2024). The Effect of Green Investment, Corporate Social Responsibility, and Good Corporate Governance on Green Company Value Mediated by Return on Investment. 8(3). 673–687. 7 indexed citations

Gunawan, Steven, et al.. (2021). Oxidations of pyrrolidines and piperidines to afford CH-functionalized isopropyl-1-carboxylate congeners. Tetrahedron Letters. 69. 152978–152978. 1 indexed citations

Zhu, J., Andreas Becker, Norbert Berndt, et al.. (2021). Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors. Journal of Medicinal Chemistry. 64(21). 15772–15786. 20 indexed citations

Davis, Ryan R., Baoli Li, Steven Gunawan, et al.. (2021). Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof. Journal of Medicinal Chemistry. 64(4). 2228–2241. 68 indexed citations

Khatimah, Husnul, et al.. (2021). Spontaneous intracerebral hemorrhage after anticoagulation therapy in a 57-year-old man with SARS-COV-2 infection: A case report. Journal of the Neurological Sciences. 429. 119785–119785.

Handoko, Bambang Leo, et al.. (2019). Facing Industry Revolution 4.0 for Millennial Accountants. International Journal of Innovative Technology and Exploring Engineering. 9(1). 1037–1042. 5 indexed citations

Sun, Xiaojun, Yuan Ren, Steven Gunawan, et al.. (2018). Selective inhibition of leukemia-associated SHP2E69K mutant by the allosteric SHP2 inhibitor SHP099. Leukemia. 32(5). 1246–1249. 53 indexed citations

Sun, Xiaojun, Yuan Ren, Steven Gunawan, et al.. (2018). Abstract 4879: Mutation selectivity of the allosteric SHP2 inhibitor SHP099. Cancer Research. 78(13_Supplement). 4879–4879. 1 indexed citations

Ember, S.W., Que T. Lambert, Norbert Berndt, et al.. (2017). Potent Dual BET Bromodomain-Kinase Inhibitors as Value-Added Multitargeted Chemical Probes and Cancer Therapeutics. Molecular Cancer Therapeutics. 16(6). 1054–1067. 41 indexed citations

10.

Betts, Brian C., Anandharaman Veerapathran, Joseph Pidala, et al.. (2017). Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining T _reg and antitumor CTL function. Science Translational Medicine. 9(372). 32 indexed citations

11.

Gunawan, Steven. (2016). TINJAUAN YURIDIS PEREMPUAN SEBAGAI KORBAN KEKERASAN DALAM RUMAH TANGGA DITINJAU DARI UNDANG-UNDANG NOMOR 23 TAHUN 2004 TENTANG PENGHAPUSAN KEKERASAN DALAM RUMAH TANGGA. CALYPTRA : Jurnal Ilmiah Mahasiswa Universitas Surabaya. 4(2). 1–13. 1 indexed citations

12.

Gunawan, Steven, S.W. Ember, J. Zhu, et al.. (2015). Abstract 3643: Targeting the acetyl-lysine binding site of BRD4 with dual nanomolar BET-JAK2 inhibitors: A new anticancer therapeutic strategy. Cancer Research. 75(15_Supplement). 3643–3643. 1 indexed citations

13.

Gunawan, Steven & Christopher Hulme. (2013). Bifunctional building blocks in the Ugi-azide condensation reaction: a general strategy toward exploration of new molecular diversity. Organic & Biomolecular Chemistry. 11(36). 6036–6036. 40 indexed citations

14.

Gunawan, Steven & Christopher Hulme. (2013). Construction of functionalized tricyclic dihydropyrazino-quinazolinedione chemotypes via an Ugi/N-acyliminium ion cyclization cascade. Tetrahedron Letters. 54(33). 4467–4470. 11 indexed citations

15.

Gunawan, Steven, Muhammad Ayaz, Fabio De Moliner, et al.. (2012). Synthesis of tetrazolo-fused benzodiazepines and benzodiazepinones by a two-step protocol using an Ugi-azide reaction for initial diversity generation. Tetrahedron. 68(27-28). 5606–5611. 38 indexed citations

16.

Gunawan, Steven, et al.. (2012). Synthesis of peptidomimetics, δ- and $${\varepsilon}$$ -lactam tetrazoles. Molecular Diversity. 16(3). 601–606. 12 indexed citations

17.

Gunawan, Steven, Gary S. Nichol, & Christopher Hulme. (2012). Concise route to a series of novel 3-(tetrazol-5-yl)quinoxalin-2(1H)-ones. Tetrahedron Letters. 53(13). 1664–1667. 16 indexed citations

18.

Gunawan, Steven, et al.. (2010). Concise preparation of novel tricyclic chemotypes: fused hydantoin–benzodiazepines. Tetrahedron Letters. 51(36). 4689–4692. 22 indexed citations

19.

Nichol, Gary S., Steven Gunawan, Zhigang Xu, Justin Dietrich, & Christopher Hulme. (2010). 2-Propyl 3,3-dibromo-2-hydroxypyrrolidine-1-carboxylate. Acta Crystallographica Section E Structure Reports Online. 66(3). o597–o597. 1 indexed citations

20.

Nichol, Gary S., Steven Gunawan, Justin Dietrich, & Christopher Hulme. (2010). 2-Butyl-11-phenyl-5,10-dihydro-1H-benzo[e]imidazo[1,5-a][1,4]diazepine-1,3(2H)-dione. Acta Crystallographica Section E Structure Reports Online. 66(3). o625–o625. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact